The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Compliance with Results Reporting at ClinicalTrials.gov
Open accessAbstract
BACKGROUND: The Food and Drug Administration Amendments Act (FDAAA) mandates timely reporting of results of applicable clinical trials to ClinicalTrials.gov. We characterized the proportion of applicable clinical trials with publicly available results and determined independent factors associated with the reporting of results. METHODS: Using an algorithm based on input from the National Library of Medicine, we identified trials that were likely to be subject to FDAAA provisions (highly likely applicable clinical trials, or HLACTs) from 2008 through 2013. We determined the proportion of HLACTs that reported results within the 12-month interval mandated by the FDAAA or at any time during the 5-year study period. We used regression models to examine characteristics associated with reporting at 12 months and throughout the 5-year study period. RESULTS: From all the trials at ClinicalTrials.gov, we identified 13,327 HLACTs that were terminated or completed from January 1, 2008, through August 31, 2012. Of these trials, 77.4% were classified as drug trials. A total of 36.9% of the trials were phase 2 studies, and 23.4% were phase 3 studies; 65.6% were funded by industry. Only 13.4% of trials reported summary results within 12 months after trial completion, whereas 38.3% reported results at any time up to September 27, 2013. Timely reporting was independently associated with factors such as FDA oversight, a later trial phase, and industry funding. A sample review suggested that 45% of industry-funded trials were not required to report results, as compared with 6% of trials funded by the National Institutes of Health (NIH) and 9% of trials that were funded by other government or academic institutions. CONCLUSIONS: Despite ethical and legal obligations to disclose findings promptly, most HLACTs did not report results to ClinicalTrials.gov in a timely fashion during the study period. Industry-funded trials adhered to legal obligations more often than did trials funded by the NIH or other government or academic institutions. (Funded by the Clinical Trials Transformation Initiative and the NIH.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
What Makes Clinical Research Ethical?
Emanuel, E. J. (2000) · JAMA · doi:10.1001/jama.283.20.2701 · Cited by 2,710
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Self-citationCharacteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010
Califf, R. M. (2012) · JAMA · doi:10.1001/jama.2012.3424 · Cited by 516
Self-citationClinical Trial Registration — Looking Back and Moving Ahead
Laine, C. M., Horton, R. C., DeAngelis, C. D., Drazen, J. M., Frizelle, F., Godlee, F., Haug, C. J., Hébert, P. C., Kotzin, S., Marušić, A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejme078110 · Cited by 320
Prayle, A., Hurley, M. N., & Smyth, A. R. (2012) · BMJ · doi:10.1136/bmj.d7373 · Cited by 299
Disclosing Individual Results of Clinical Research: Implications of Respect for Participants
Shalowitz, D. I., & Miller, F. G. (2005) · JAMA · doi:10.1001/jama.294.6.737 · Cited by 265
Tasneem, A., Aberle, L. H., Ananth, H., Chakraborty, S., Chiswell, K., McCourt, B. J., & Pietrobon, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033677 · Cited by 176
Self-citationLaine, C. M., Horton, R. C., DeAngelis, C. D., Drazen, J. M., Frizelle, F., Godlee, F., Haug, C. J., Hébert, P. C., Kotzin, S., Marušić, A., et al. (2007) · JAMA · doi:10.1001/jama.298.1.jed70037 · Cited by 135
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 381
van Heteren, J. A. A., van Beurden, I., Peters, J. P. M., Smit, A. L., & Stegeman, I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219458 · Cited by 26
Publication status of contemporary oncology randomised controlled trials worldwide
Chen, Y., Liu, X., Lv, J.-W., Li, W., Zhang, Y., Guo, Y. Q., Lin, A.-H., Sun, Y. H., Mao, Y., & Ma, J. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.06.010 · Cited by 25
Ruopp, M. D., Chiswell, K., Thaden, J. T., Merchant, K., & Tsalik, E. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201505-291oc · Cited by 24
Self-citationDeVito, N., Bacon, S., & Goldacre, B. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/266452 · Cited by 26
Long, J., Liang, R., Zheng, Q., Yuan, G., Xin, Z., Chen, X., Lai, F., & Liu, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s288065 · Cited by 22
Evaluation of Oncology Trial Results Reporting Over a 10-Year Period
Liu, X., Zhang, Y., Li, W., Vokes, E. E., Sun, Y. H., Le, Q., & Ma, J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.10438 · Cited by 23
Dietz, V. A., Roberts, N., Knox, K., Moore, S., Pitonak, M., Barr, C., Centeno, J., Leininger, S., New, K. C., Nowell̀, P. C., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.977679 · Cited by 23
Sobczyk, M., Zheng, J., Smith, G. D., & Gaunt, T. R. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072087 · Cited by 26
Anderson, L. N., Hoyt, C. T., Zucker, J., McNaughton, A. D., Teuton, J., Karis, K., Arokium-Christian, N. N., Warley, J. T., Stromberg, Z. R., Gyori, B. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1502484 · Cited by 26
Nanavati, H. D., Andrabi, M. S., Arevalo, Y. A., Liu, E., Shen, J. Z., & Lin, C. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033467 · Cited by 21
From registration to publication: A study on Dutch academic randomized controlled trials
Huiskens, J., Kool, B. R. J., Bakker, J.-M., Bruns, E. R. J., de Jonge, S. W., Olthof, P. B., van Rosmalen, B. V., van Gulik, T. M., Hooft, L., & Punt, C. J. A. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1379 · Cited by 22
Cummings, J. L. (2020) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20060152 · Cited by 21
Focus on sharing individual patient data distracts from other ways of improving trial transparency
Hoffmann, T., Glasziou, P., Beller, E., Goldacre, B. M., & Chalmers, I. (2017) · BMJ · doi:10.1136/bmj.j2782 · Cited by 19
Real-World Evidence in the Real World: Beyond the FDA
Krause, J. H., & Saver, R. S. (2018) · American Journal of Law & Medicine · doi:10.1177/0098858818789423 · Cited by 20
Gupta, M., Petsalis, M., Powers, K., Chen, H.-Y., Chauhan, S., & Wagner, S. (2020) · European Journal of Obstetrics, Gynecology, and Reproductive Biology · doi:10.1016/j.ejogrb.2020.05.060 · Cited by 15
Steinberg, J. R., Magnani, C. J., Turner, B. E., Weeks, B. T., Young, A. M. P., Lu, C. F., Zhang, N., Richardson, M. T., Fitzgerald, A. C., Mekonnen, Z. K., et al. (2022) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004735 · Cited by 17
Lampert, A., Hoffmann, G. F., & Ries, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144973 · Cited by 19
Gan, J., Wang, Y., & Zhou, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6769 · Cited by 17
Turner, B. E., Magnani, C. J., Frolov, A., Weeks, B. T., Steinberg, J. R., Huda, N., Shah, L. M., Zuroff, L. R., Gu, B. J., Rasmussen, H. K., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117579 · Cited by 18
Bagg, M. K., O’Hagan, E. T., Zahara, P., Wand, B. M., Hübscher, M., Moseley, G. L., & McAuley, J. H. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.006 · Cited by 19
Elghafari, A., & Finkelstein, J. (2021) · JMIR Medical Informatics · doi:10.2196/18298 · Cited by 19
Garzotto, F., Comoretto, R. I., Dorigo, L., Gregori, D., Zotti, A., Meneghesso, G., Gerosa, G., & Bonin, M. (2022) · Expert Review of Medical Devices · doi:10.1080/17434440.2022.2118046 · Cited by 17
Pansieri, C., Pandolfini, C., & Bonati, M. R. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1897-9 · Cited by 18
Developing timely insights into comparative effectiveness research with a text-mining pipeline
Chang, M., Chang, M., Reed, J. Z., Milward, D., Xu, J. J., & Cornell, W. D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.012 · Cited by 18
Axson, S. A., Mello, M. M., Lincow, D., Yang, C. F., Gross, C. P., Ross, J. S., & Miller, J. E. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053248 · Cited by 17
Compliance with Results Reporting at ClinicalTrials.gov
Hallinan, Z. P., Getz, K. A., & Bierer, B. E. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1504513 · Cited by 17
Morgan, B., Hejdenberg, J., Kuleszewicz, K., Armstrong, D., & Ziebland, S. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00931-y · Cited by 16
Penlington, M., Goulet, P., & Metcalfe, B. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.12.045 · Cited by 15
Clinical trial registry use in anaesthesiology systematic reviews
Umberham, B. A., Detweiler, B., Sims, M. T., & Vassar, M. B. (2017) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000671 · Cited by 16
Is it time for computable evidence synthesis?
Dunn, A. G., & Bourgeois, F. T. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa035 · Cited by 15
Lack of Transparency in Publishing Negative Clinical Trial Results
Snyder, R. (2020) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2019.12.013 · Cited by 15
Tompson, A., Petit-Zeman, S., Goldacre, B. M., & Heneghan, C. J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009285 · Cited by 14
Serpas, V., Raghav, K. P. S., Halperin, D. M., Yao, J. C., & Overman, M. J. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0627-2 · Cited by 14
Assessing the adoption of clinical trial results summary disclosure to patients and the public
Getz, K., & Farides-Mitchell, J. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1615441 · Cited by 15
Dechartres, A., Riveros, C., Harroch, M., Faber, T., & Ravaud, P. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.0137 · Cited by 15
Lindsley, K., Fusco, N., Teeuw, H., Mooij, E., Scholten, R., & Hooft, L. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.12.016 · Cited by 14
The Application of Evidence-Based Medicine in Individualized Medicine
de Vliet, P. V., Sprenger, T., Kampers, L. F. C., Makalowski, J., Schirrmacher, V., Stücker, W., & Gool, S. V. (2023) · Biomedicines · doi:10.3390/biomedicines11071793 · Cited by 14
Underperformance of Contemporary Phase III Oncology Trials and Strategies for Improvement
Shen, C., Ferro, E. G., Xu, H., Kramer, D. B., Patell, R. D., & Kazi, D. S. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7690 · Cited by 16
Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey
Flacco, M. E., Manzoli, L., Boccia, S., Puggina, A., Rosso, A., Marzuillo, C., Scaioli, G., Gualano, M. R., Ricciardi, W., Villari, P., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.032 · Cited by 14
Publicly funded practice-oriented clinical trials: of importance for healthcare payers
Neyt, M., Christiaens, T., Demotes‐Mainard, J., Walley, T., & Hulstaert, F. (2016) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2016-0018 · Cited by 14
Publication and Outcome Reporting Bias
Marks‐Anglin, A., Duan, R., Chen, Y., Panagiotou, O. A., & Schmid, C. H. (2020) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315119403-13 · Cited by 14
Gastelum-Leyva, F., Jasso, A. P., Alvarado-Vera, M., López, I. P., Romero, L. P., Loera‐Castañeda, V., Mireles, J. A. G., Lares‐Asseff, I., Leal-Ávila, M. Á., Alvelais-Palacios, J. A., et al. (2022) · Viruses · doi:10.3390/v14112329 · Cited by 16
Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry
Kao, J. L. (2024) · Management Science · doi:10.1287/mnsc.2022.01161 · Cited by 14
Barnett, A. G., & Glasziou, P. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053377 · Cited by 13
Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years
Pellat, A., Boutron, I., & Ravaud, P. (2022) · The Oncologist · doi:10.1093/oncolo/oyac156 · Cited by 12
Trial-Results Reporting and Academic Medical Centers
Zarin, D. A., Tse, T., & Ross, J. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505965 · Cited by 13
Publication Rates of Heart Failure Clinical Trials Remain Low
Psotka, M. A., Latta, F., Cani, D., Fiuzat, M., Sbolli, M., Barnett, S. D., Metra, M., & O’Connor, C. M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.068 · Cited by 13
Ukegjini, K., Guidi, M., Lehmann, K., Süveg, K., Putora, P. M., Čihorić, N., & Steffen, T. (2023) · Cancers · doi:10.3390/cancers15071926 · Cited by 12
Hernández, J. M. D. L. T., & Edelman, E. R. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.07.017 · Cited by 13
Knowles, R. L., Ha, K. P., Mueller, J., Rawle, F. C., & Parker, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035283 · Cited by 11
Mechler, K., Hoffmann, G. F., Dittmann, R., & Ries, M. (2016) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1546 · Cited by 13
Chen, K. Y., Borglund, E. M., Postema, E. C., Dunn, A. G., & Bourgeois, F. T. (2022) · Clinical Trials · doi:10.1177/17407745221093567 · Cited by 13
Chen, Y., Lv, J.-W., Liu, X., Zhang, Y., Guo, Y. Q., Lin, A.-H., Sun, Y. H., Mao, Y., & Ma, J. (2016) · Theranostics · doi:10.7150/thno.17087 · Cited by 12
Nilsonne, G., Wieschowski, S., DeVito, N., Salholz‐Hillel, M., Ahnström, L., Brückner, T., Klaś, K., Suljić, T., Yerunkar, S. S., Olsson, N., et al. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111710 · Cited by 9
Williams, M. J., Mullane, K., & Curtis, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804725-5.00005-7 · Cited by 10
Goodwin, T. R., Skinner, M. A., & Harabagiu, S. M. (2018) · Europe PMC (PubMed Central) · Cited by 10
Regulatory Approval and Biotechnology Product Disclosures*†
Enache, L., Li, L., & Riedl, E. J. (2022) · Contemporary Accounting Research · doi:10.1111/1911-3846.12758 · Cited by 13
The enforcement of mandatory disclosure rules
Dahm, M., González, P., & Porteiro, N. (2018) · Journal of Public Economics · doi:10.1016/j.jpubeco.2018.08.014 · Cited by 10
Cahan, A., & Anand, V. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185886 · Cited by 10
Rawal, B., & Deane, B. R. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1047749 · Cited by 10
Ethics framework for treatment use of investigational drugs
Borysowski, J., & Górski, A. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00560-9 · Cited by 10
Who funds Alzheimer's disease drug development?
Cummings, J. L., Bauzon, J. S., & Lee, G. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12185 · Cited by 9
Hartwell, M. L., Sajjadi, N. B., Shepard, S., Whelan, J., Roberts, J. N., Ford, A. I., Beaman, J., & Vassar, M. B. (2022) · Substance Abuse · doi:10.1080/08897077.2021.2010261 · Cited by 9
Fain, K. M., Rajakannan, T., Tse, T., Williams, R. J., & Zarin, D. A. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0263 · Cited by 11
Gender Diversity of Research Teams and Clinical Trial Enrollment
Gupta, H., Jena, A. B., & Sun, E. C. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.37667 · Cited by 9
Ensuring Respect for Human Research Participants
Doernberg, S. N., & Wendler, D. S. (2016) · JAMA · doi:10.1001/jama.2016.7970 · Cited by 9
Guenova, M. L., Schäfer, R., & Palange, P. (2019) · Journal of European CME · doi:10.1080/21614083.2019.1690321 · Cited by 9
Schindler, T. M., Grieger, F., Zak, A., Rorig, R., Konka, K. C., Ellsworth, A., Pfitzer, C., Hodge, K., & Crandall, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233294 · Cited by 11
Penlington, M., Silverman, H. I., Vasudevan, A., & Pavithran, P. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00359-4 · Cited by 9
Riley, W. T., Bibb, K., Hargrave, S. L., & Fearon, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242271 · Cited by 9
Cooper, C., Court, R. A., Kotas, E., & Schauberger, U. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1477 · Cited by 10
Liang, R., Long, J., Zheng, Q., Yuan, G., Chen, X., Xin, Z., Lai, F., & Liu, Y. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01627-0 · Cited by 9
Jin, G. Z., Luca, M., & Martin, D. J. (2018) · National Bureau of Economic Research · doi:10.3386/w24675 · Cited by 9
Registration, reporting, and replication in clinical trials: The case of anorexia nervosa
Murray, S. B., Compte, E. J., Quintana, D. S., Mitchison, D., Griffiths, S., & Nagata, J. M. (2019) · International Journal of Eating Disorders · doi:10.1002/eat.23187 · Cited by 8
Reproducibility failure in biomedical research: problems and solutions
Haven, T. L., & Ioannidis, J. P. A. (2026) · Annual Review of Medicine · doi:10.1146/annurev-med-050124-050859 · Cited by 9
Schmaling, K. B., Landon, H. S., Nguyen, T. B., & Kaplan, R. M. (2021) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111641 · Cited by 9
Chen, D., Cao, C., Kloosterman, R., Parsa, R., & Raman, S. (2024) · Journal of Medical Internet Research · doi:10.2196/58578 · Cited by 10
Clinical Research after COVID-19: Embracing a New Normal
Gelfand, J. M., & Hefele, B. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.08.004 · Cited by 8
Meyburg, J., & Ries, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037346 · Cited by 8
Study design, result posting, and publication of late-stage cardiovascular trials
Kapelios, C. J., Naci, H., Vardas, P. E., & Mossialos, E. A. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa080 · Cited by 8
The Invisible Hand of Industry
Guo, X. M., & Barber, E. L. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000697 · Cited by 8
Binko, M. A., Reitz, K. M., Chaer, R. A., Haga, L. M., Go, C. C., Alie-Cusson, F. S., Tzeng, E., Eslami, M. H., & Sridharan, N. D. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2023.05.035 · Cited by 8
An Assessment of Publication Status of Pediatric Liver Transplantation Studies
Breil, T., Wenning, D., Teufel, U., Hoffmann, G. F., & Ries, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168251 · Cited by 8
Reporting Compliance of Stroke Trials: Cross-Sectional Analysis
Malhotra, K., Rayi, A., Khunger, M., Thompson, S., & Liebeskind, D. S. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.03.010 · Cited by 8
Folkers, K. M., Leone, S., & Caplan, A. L. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4745-7 · Cited by 8
Current state of clinical trials regarding liver transplant rejection
Masri, J. E., Ayoubi, L. M. E., Zreika, B., Adhami, F., Masri, D. E., Hage, S. E., & Abou-Jaoudé, M. M. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101522 · Cited by 8
Breil, T., Boettcher, M., Hoffmann, G. F., & Ries, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021684 · Cited by 8
Koch, A. R., Craemer, K. A., Garland, C. E., Fox, W. B., Jones, C. T., Qualls, A. C., Sterr, J. C., & Geller, S. E. (2024) · Journal of Women's Health · doi:10.1089/jwh.2023.0307 · Cited by 7
Fan, R., Zheng, Y., Zhou, R., Beeraka, N. M., Sukocheva, O. A., Zhao, R., Li, S., Zhao, X. Y., Liu, C., He, S., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1203346 · Cited by 8
Dal‐Ré, R. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12694 · Cited by 7
Cuschieri, S. (2019) · Saudi Journal of Anaesthesia · doi:10.4103/sja.sja_575_18 · Cited by 6
Registration of phase 3 crossover trials on ClinicalTrials.gov
Zeng, L., Qureshı, R., Viswanathan, S., Drye, L. T., & Li, T. (2020) · Trials · doi:10.1186/s13063-020-04545-2 · Cited by 7
Publication rate and characteristics of cancer clinical trials in India
Thomas, V. M., John, V. M., Alexander, S. A., Roy, A. M., & Mathew, A. (2020) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2020.100248 · Cited by 7
Liu, Y., Ли, Б., Zheng, Q., Xu, J. H., Li, J., Lai, F., Lin, B., Peng, S., Lv, W., & Xiao, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.575799 · Cited by 7
Thiele, C., Hirschfeld, G. H. F., & von Brachel, R. (2021) · Scientometrics · doi:10.1007/s11192-021-04111-w · Cited by 7
Naci, H., Cooper, J., & Mossialos, E. A. (2015) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcv012 · Cited by 7
Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect
Mintzes, B. J., Lexchin, J., & Santos, A. L. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv042 · Cited by 8
Opportunities and challenges for junior investigators conducting pain clinical trials
Adams, M. C. B., Bicket, M. C., Murphy, J. D., Wu, C. L., & Hurley, R. W. (2018) · PAIN Reports · doi:10.1097/pr9.0000000000000639 · Cited by 7
The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials
Patel, R. B., Venkateswaran, R. V., Singh, A., Bhatt, D. L., Fonarow, G. C., PASSMAN, R. S., Butler, J., Yancy, C. W., & Vaduganathan, M. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.04.008 · Cited by 7
Removing the blindfold on medicines pricing
Moon, S. (2018) · BMJ · doi:10.1136/bmj.k840 · Cited by 7
Metadata
- Authors
- Anderson, M. L., Chiswell, K., Peterson, E. D., Tasneem, A., Topping, J., & Califf, R. M.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-12
- Volume
- 372
- Issue
- 11
- Pages
- 1031-1039
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4508873
- OpenAlex
- W1963526469
- Cited by
- 380
- References
- 19
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 17 · 2023: 18 · 2022: 36 · 2021: 33 · 2020: 37 · 2019: 28 · 2018: 51 · 2017: 38 · 2016: 50 · 2015: 36
- FWCI
- 68.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- New England Journal of Medicine (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. National Library of Medicine
- Duke Clinical Research Institute
- National Center for Complementary and Integrative Health (U54AT007748)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- ClinicalTrials.gov, result reporting, clinical trial transparency, regulatory compliance, industry-funded trials, trial phase, FDA oversight, drug trials
- MeSH terms
- Algorithms, Clinical Trials as Topic, Drug Industry, Humans, National Library of Medicine (U.S.), Registries, Research Support as Topic, United States, United States Food and Drug Administration, Proportional Hazards Models, Databases, Factual, Disclosure, Government Regulation, Mandatory Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
